Representative before the EPO

Technology company logo thumb
no operation time available
3 offices
Technology Company

We have observed 83 EP applications Stephanie Anne Learoyd has served for within the last five+ years. (We consider all applications which have an EP A1 or A2 publication dated after June 22, 2013). Please note, that we only count EP applications, in which the name of the patent attorney is explicitly mentioned as representative. These EP applications are:

EP11785351

METHOD OF TREATMENT BASED ON ATAD2 INHIBITORS

IPC classification:
A61P 37/00, A61P 29/00, C12N 9/14, A61K 31/713, C12Q 1/34, C12N 15/113
Applicant:
Glaxo Group Limited
Agent:
Stephanie Anne Learoyd, GlaxoSmithKline
Status:
The patent has been granted
EP11791249

INHIBITORS OF SP140 AND THEIR USE IN THERAPY

IPC classification:
A61P 37/06, A61P 35/00, A61P 29/00, A61K 31/713, C12N 15/113
Applicant:
Glaxo Group Limited
Agent:
Stephanie Anne Learoyd, GlaxoSmithKline
Status:
The patent has been granted
EP12702947

C-17 AND C-3 MODIFIED TRITERPENOIDS WITH HIV MATURATION INHIBITORY ACTIVITY

IPC classification:
A61P 31/18, A61K 31/56, C07J 63/00
Applicant:
Bristol-Myers Squibb Company
Agent:
Stephanie Anne Learoyd, GlaxoSmithKline
Agent:
Reitstötter Kinzebach & Partner GbR
Status:
The patent has been granted
EP12822366

CHEMICAL COMPOUNDS

IPC classification:
A61K 31/4178, C07D 403/14
Applicant:
GlaxoSmithKline LLC
Agent:
Stephanie Anne Learoyd, GlaxoSmithKline
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12727669

TUMOUR NECROSIS FACTOR RECEPTOR 1 ANTAGONISTS

IPC classification:
A61K 39/395, C07K 16/28
Applicant:
Glaxo Group Limited
Agent:
Multiple attorneys, GlaxoSmithKline
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12824263

AMINO QUINAZOLINES AS KINASE INHIBITORS

IPC classification:
A61K 31/535
Applicant:
GlaxoSmithKline Intellectual Property Development Limited
Agent:
Stephanie Anne Learoyd, GlaxoSmithKline
Status:
PATENT GRANTED
EP12766825

NOVEL BETULINIC ACID DERIVATIVES WITH ANTIVIRAL ACTIVITY

IPC classification:
A61K 31/56, C07J 63/00, A61P 31/18
Applicant:
Bristol-Myers Squibb Company
Agent:
Stephanie Anne Learoyd, GlaxoSmithKline
Agent:
Reitstötter Kinzebach & Partner GbR
Status:
PATENT GRANTED
EP12826268

COMBINATION TREATMENTS FOR HEPATITIS C

IPC classification:
A61K 31/40, A01N 43/38, A01N 37/18, A61P 1/16
Applicant:
GlaxoSmithKline LLC
Agent:
Stephanie Anne Learoyd, GlaxoSmithKline
Agent:
Cornelis Marinus Jansen, Vereenigde Octrooibureaux NV (V.O.)
Status:
GRANT OF PATENT INTENDED
EP12844715

PAZOPANIB FORMULATION

IPC classification:
A01N 43/40
Applicant:
Novartis AG
Applicant:
GlaxoSmithKline Intellectual Property Limited
Applicant:
GlaxoSmithKline Intellectual Property Management Limited
Agent:
Markus Gruber, Novartis Pharma AG
Agent:
Stephanie Anne Learoyd, GlaxoSmithKline
Status:
EXAMINATION IN PROGRESS
EP13738466

COMPOSITIONS AND METHODS FOR TREATING DIABETES AND/OR OBESITY

IPC classification:
A61K 38/00, A01N 43/04
Applicant:
GlaxoSmithkline Intellectual Property (No. 2) Limited
Agent:
Stephanie Anne Learoyd, GlaxoSmithKline
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13707493

C-3 CYCLOALKENYL TRITERPENOIDS WITH HIV MATURATION INHIBITORY ACTIVITY

IPC classification:
A61K 31/58, A61K 31/575, C07J 63/00, A61P 31/18
Applicant:
Bristol-Myers Squibb Company
Agent:
Stephanie Anne Learoyd, GlaxoSmithKline
Agent:
Regina Vögeli-Lange, Swords Laboratories
Agent:
Reitstötter Kinzebach & Partner GbR
Status:
The patent has been granted
EP13705712

INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION

IPC classification:
A61K 31/4375, C07D 471/04, A61P 31/18
Applicant:
Bristol-Myers Squibb Company
Agent:
Stephanie Anne Learoyd, GlaxoSmithKline
Agent:
Regina Vögeli-Lange, Swords Laboratories
Status:
The patent has been granted
EP12857774

DERIVATIVES OF BETULIN

IPC classification:
C07C 69/753
Applicant:
GlaxoSmithKline LLC
Agent:
Stephanie Anne Learoyd, GlaxoSmithKline
Status:
The patent has been granted
EP12856832

PROPENOATE DERIVATIVES OF BETULIN

IPC classification:
C07C 69/753
Applicant:
GlaxoSmithKline LLC
Agent:
Stephanie Anne Learoyd, GlaxoSmithKline
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP13710240

FUSED PYRIMIDINES AS INHIBITORS OF IMMUNODEFICIENCY VIRUS REPLICATION

IPC classification:
A61K 31/519, C07D 487/04, A61P 31/18
Applicant:
Bristol-Myers Squibb Company
Agent:
Stephanie Anne Learoyd, GlaxoSmithKline
Agent:
Reitstötter Kinzebach & Partner GbR
Status:
PATENT GRANTED
EP13710940

INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION

IPC classification:
A61K 31/519, C07D 487/04, A61P 31/18
Applicant:
Bristol-Myers Squibb Company
Agent:
Stephanie Anne Learoyd, GlaxoSmithKline
Agent:
Regina Vögeli-Lange, Swords Laboratories
Agent:
Reitstötter Kinzebach & Partner GbR
Status:
PATENT GRANTED
EP12824599

THERAPEUTIC METHODS

IPC classification:
A61K 31/69, A01N 55/08, A61P 31/12
Applicant:
GlaxoSmithKline LLC
Agent:
Stephanie Anne Learoyd, GlaxoSmithKline
Status:
EXAMINATION IN PROGRESS
EP13722947

C-17 BICYCLIC AMINES OF TRITERPENOIDS WITH HIV MATURATION INHIBITORY ACTIVITY

IPC classification:
A61K 31/56, C07J 63/00, A61P 31/18
Applicant:
Bristol-Myers Squibb Company
Agent:
Stephanie Anne Learoyd, GlaxoSmithKline
Agent:
Regina Vögeli-Lange, Swords Laboratories
Agent:
Reitstötter Kinzebach & Partner GbR
Status:
The patent has been granted
EP13750479

INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION

IPC classification:
A61K 31/519, C07D 498/16, C07D 487/16, A61P 31/18
Applicant:
Bristol-Myers Squibb Company
Agent:
Stephanie Anne Learoyd, GlaxoSmithKline
Agent:
Regina Vögeli-Lange, Swords Laboratories
Status:
PATENT GRANTED
EP13759172

INHIBITORS OF BROMODOMAIN-CONTAINING PROTEIN PCAF FOR THE TREATMENT OF AUTOIMMUNE AND INFLAMMATORY DISEASES OR FOR THE TREATMENT OF CANCER

IPC classification:
A61K 31/7105, G01N 1/00
Applicant:
Glaxo Group Limited
Agent:
Stephanie Anne Learoyd, GlaxoSmithKline
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13863026

PHARMACEUTICAL COMPOSITIONS

IPC classification:
A61K 31/568, C07J 63/00, C07C 69/74, A61P 31/18
Applicant:
GlaxoSmithKline LLC
Agent:
Stephanie Anne Learoyd, GlaxoSmithKline
Status:
GRANT OF PATENT INTENDED
EP14705662

C-19 MODIFIED TRITERPENOIDS WITH HIV MATURATION INHIBITORY ACTIVITY

IPC classification:
A61K 31/18, A61K 31/56, C07J 63/00
Applicant:
Bristol-Myers Squibb Company
Agent:
Stephanie Anne Learoyd, GlaxoSmithKline
Agent:
Reitstötter Kinzebach & Partner GbR
Status:
EXAMINATION REQUESTED
EP14710687

C-3 ALKYL AND ALKENYL MODIFIED BETULINIC ACID DERIVATIVES USEFUL IN THE TREATMENT OF HIV

IPC classification:
A61P 31/18, A61K 31/56, C07J 63/00
Applicant:
Bristol-Myers Squibb Company
Agent:
Reitstötter Kinzebach & Partner GbR
Agent:
Stephanie Anne Learoyd, GlaxoSmithKline
Status:
EXAMINATION REQUESTED
EP14715481

INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION

IPC classification:
A61P 31/18, C07D 498/22, C07D 498/16, C07D 487/16, A61K 31/5383, A61K 31/519, C07D 487/04
Applicant:
Bristol-Myers Squibb Company
Agent:
Stephanie Anne Learoyd, GlaxoSmithKline
Agent:
Reitstötter Kinzebach & Partner GbR
Status:
EXAMINATION REQUESTED
EP14725559

INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION

IPC classification:
A61P 31/18, A61K 31/437, C07D 471/04
Applicant:
Bristol-Myers Squibb Company
Agent:
Stephanie Anne Learoyd, GlaxoSmithKline
Agent:
Reitstötter Kinzebach & Partner GbR
Status:
PATENT GRANTED
EP14727271

INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION

IPC classification:
A61P 31/18, A61K 31/429, C07D 519/00, C07D 471/04
Applicant:
Bristol-Myers Squibb Company
Agent:
Stephanie Anne Learoyd, GlaxoSmithKline
Agent:
Reitstötter Kinzebach & Partner GbR
Status:
PATENT GRANTED
EP14718804

INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION

IPC classification:
A61P 31/18, A61K 31/529, C07D 515/22, C07D 513/22, C07D 498/22, C07D 498/18, C07D 487/04
Applicant:
Bristol-Myers Squibb Company
Agent:
Stephanie Anne Learoyd, GlaxoSmithKline
Agent:
Reitstötter Kinzebach & Partner GbR
Status:
PATENT GRANTED
EP14717006

INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION

IPC classification:
A61K 31/519, A61P 31/18, C07D 487/04
Applicant:
Bristol-Myers Squibb Company
Agent:
Stephanie Anne Learoyd, GlaxoSmithKline
Agent:
Reitstötter Kinzebach & Partner GbR
Status:
EXAMINATION IN PROGRESS
EP14734147

NOVEL COMPOUNDS

IPC classification:
A61P 35/00, A61K 31/427, C07K 5/078
Applicant:
GlaxoSmithKline Intellectual Property Development Limited
Agent:
Joseph Lenthall, Mewburn Ellis LLP
Agent:
Stephanie Anne Learoyd, GlaxoSmithKline
Status:
EXAMINATION IN PROGRESS
EP14734146

BENZOTHIOPHENE DERIVATIVES AS ESTROGEN RECEPTOR INHIBITORS

IPC classification:
A61P 5/30, A61K 31/422, A61K 31/427, C07D 417/14, C07D 413/14, C07D 409/14, C07D 409/12
Applicant:
GlaxoSmithKline Intellectual Property Development Limited
Agent:
Joseph Lenthall, Mewburn Ellis LLP
Agent:
Stephanie Anne Learoyd, GlaxoSmithKline
Status:
EXAMINATION IN PROGRESS
EP11772961

PYRAZOLE COMPOUNDS ACTING AGAINST ALLERGIC, IMMUNE AND INFLAMMATORY CONDITIONS

IPC classification:
A61P 37/00, A61P 29/00, A61P 11/00, A61K 31/415, C07D 231/38
Applicant:
Glaxo Group Limited
Agent:
Stephanie Anne Learoyd, GlaxoSmithKline
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP14799920

INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION

IPC classification:
C07D 205/04, C07D 261/08, C07D 249/08, C07D 409/12, C07D 311/58, C07D 401/04, C07D 233/54, C07D 233/38, C07D 333/28, C07D 333/18, C07D 231/12, C07D 317/66, C07D 311/04, C07D 215/08, C07D 263/56
Applicant:
Bristol-Myers Squibb Company
Agent:
Stephanie Anne Learoyd, GlaxoSmithKline
Agent:
Reitstötter Kinzebach & Partner GbR
Status:
EXAMINATION REQUESTED
EP12742225

Combination of pazopanib and topotecan

IPC classification:
A61P 35/00, C07D 231/56, A61K 45/06, A61K 31/4745, A61K 31/506
Applicant:
GlaxoSmithKline Intellectual Property Limited
Applicant:
Novartis AG
Agent:
Stephanie Anne Learoyd, GlaxoSmithKline
Agent:
Markus Gruber, Novartis Pharma AG
Status:
GRANT OF PATENT INTENDED
EP11772962

PYRAZOLE COMPOUNDS ACTING AGAINST ALLERGIC, INFLAMMATORY AND IMMUNE DISORDERS

IPC classification:
A61P 11/00, A61P 29/00, A61P 37/00, A61K 31/415, A61K 31/4155, C07D 401/12, C07D 231/38
Applicant:
Glaxo Group Limited
Agent:
Stephanie Anne Learoyd, GlaxoSmithKline
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP14799988

HYDROBROMIDE SALT OFN-(4-CHLORO-2-HYDROXY-3-((3S)-3-PIPERIDINYLSULFONYL)PHENYL-N'-(3-FLUORO-2-METHYLPHENYL)UREA

IPC classification:
A61P 11/00, A61K 31/4462, C07D 211/54
Applicant:
GlaxoSmithkline Intellectual Property (No. 2) Limited
Agent:
Stephanie Anne Learoyd, GlaxoSmithKline
Status:
EXAMINATION IN PROGRESS
EP14827868

NRF2 REGULATORS

IPC classification:
C07D 417/10
Applicant:
GlaxoSmithKline Intellectual Property Development Limited
Agent:
Stephanie Anne Learoyd, GlaxoSmithKline
Status:
EXAMINATION REQUESTED
EP15706990

BENZOTHIAZOLE MACROCYCLES AS INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION

IPC classification:
A61P 31/18, A61K 31/429, C07D 515/22, C07D 513/22, C07D 513/16
Agent:
Stephanie Anne Learoyd, GlaxoSmithKline
Status:
The patent has been granted
EP15707834

PYRAZOLOPYRIMIDINE MACROCYCLES AS INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION

IPC classification:
A61P 31/18, A61K 31/529, C07D 211/48, C07D 498/22
Agent:
Stephanie Anne Learoyd, GlaxoSmithKline
Status:
EXAMINATION REQUESTED
EP14709808

PYRAZOLOPYRIMIDINE MACROCYCLES AS INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION

IPC classification:
A61P 31/18, A61K 31/519, C07D 498/16
Applicant:
Bristol-Myers Squibb Company
Agent:
Stephanie Anne Learoyd, GlaxoSmithKline
Status:
EXAMINATION REQUESTED
EP15709381

PYRIDIN-3-YL ACETIC ACID DERIVATIVES AS INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION

IPC classification:
A61P 31/18, A61K 31/4545, C07D 213/61, C07D 417/14, C07D 409/14, C07D 401/04, C07D 413/14, C07D 401/14
Agent:
Stephanie Anne Learoyd, GlaxoSmithKline
Status:
EXAMINATION REQUESTED
EP15707839

INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION

IPC classification:
A61P 31/18, A61K 31/437, C07D 498/22, C07D 471/04
Agent:
Stephanie Anne Learoyd, GlaxoSmithKline
Status:
EXAMINATION REQUESTED
EP15709385

IMIDAZOPYRIDINE MACROCYCLES AS INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION

IPC classification:
C07D 471/04, A61P 31/18, A61K 31/4745, C07D 498/22
Agent:
Stephanie Anne Learoyd, GlaxoSmithKline
Status:
EXAMINATION REQUESTED
EP15708065

IMIDAZOPYRIMIDINE MACROCYCLES AS INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION

IPC classification:
A61P 31/18, A61K 31/529, C07D 498/22
Agent:
Stephanie Anne Learoyd, GlaxoSmithKline
Status:
EXAMINATION REQUESTED
EP15728950

PYRIDIN-3-YL ACETIC ACID MACROCYCLES AS INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION

IPC classification:
A61P 31/18, A61K 31/519, C07D 498/22
Agent:
Stephanie Anne Learoyd, GlaxoSmithKline
Status:
The patent has been granted
EP15715441

APTAMERS FOR TOPICAL DELIVERY

IPC classification:
A61K 9/107, A61K 47/26, A61K 38/00, A61K 47/14
Applicant:
GlaxoSmithKline Intellectual Property Development Limited
Agent:
Stephanie Anne Learoyd, GlaxoSmithKline
Status:
EXAMINATION REQUESTED
EP15718402

TRITERPENOIDS WITH HIV MATURATION INHIBITORY ACTIVITY, SUBSTITUTED IN POSITION 3 BY A NON-AROMATIC RING CARRYING A HALOALKYL SUBSTITUENT

IPC classification:
C07C 309/65, C07F 5/02, A61P 31/18, A61K 31/56, A61K 31/58, C07J 63/00
Agent:
Stephanie Anne Learoyd, GlaxoSmithKline
Status:
EXAMINATION REQUESTED
EP15706983

PYRAZOLOPYRIMIDINE MACROCYCLES AS INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION

IPC classification:
C07D 495/22, A61P 31/18, A61K 31/519, C07D 471/22
Agent:
Stephanie Anne Learoyd, GlaxoSmithKline
Status:
EXAMINATION REQUESTED
EP15709382

PYRAZOLOPYRIMIDINE MACROCYCLES AS INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION

IPC classification:
A61P 31/18, A61K 31/519, C07D 498/22, C07D 498/16
Agent:
Stephanie Anne Learoyd, GlaxoSmithKline
Status:
EXAMINATION REQUESTED
EP15729108

CYCLIC DI-NUCLEOTIDES AS MODULATORS OF STING

IPC classification:
A61K 31/665, A61K 31/7084, A61K 39/39, A61P 37/04, A61P 31/04, C07H 19/213, C07F 9/6574
Applicant:
GlaxoSmithKline Intellectual Property Development Limited
Agent:
Stephanie Anne Learoyd, GlaxoSmithKline
Status:
EXAMINATION REQUESTED
EP15745248

SYNTHESIS OF BENZOTHIAZEPINES

IPC classification:
A61P 3/10, A61K 31/554, C07D 281/10
Applicant:
GlaxoSmithkline Intellectual Property (No. 2) Limited
Agent:
Stephanie Anne Learoyd, GlaxoSmithKline
Status:
EXAMINATION REQUESTED
EP15762764

HETEROCYCLIC AMIDES AS RIP1 KINASE INHIBITORS AS MEDICAMENTS

IPC classification:
A61P 43/00, A61P 37/00, A61P 29/00, A61P 25/28, A61P 17/06, A61K 45/06, A61K 31/554, A61K 31/553, A61K 31/5513, A61K 31/551, A61K 31/55
Applicant:
GlaxoSmithKline Intellectual Property Development Limited
Agent:
Stephanie Anne Learoyd, GlaxoSmithKline
Status:
EXAMINATION REQUESTED
EP15760003

IMIDAZO[1,2-A]PYRIDINE DERIVATIVES FOR USE AS INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION

IPC classification:
A61P 31/18, A61K 31/437, C07D 519/00, C07D 471/04
Agent:
Stephanie Anne Learoyd, GlaxoSmithKline
Status:
EXAMINATION REQUESTED
EP15775510

LONG ACTING PHARMACEUTICAL COMPOSITIONS

IPC classification:
A61P 31/18, A61K 31/56, A61K 31/505, A61K 31/4985, A61K 9/50, A61K 9/10, A61K 47/10, A61K 9/00
Applicant:
GlaxoSmithkline Intellectual Property (No. 2) Limited
Agent:
Stephanie Anne Learoyd, GlaxoSmithKline
Status:
Request for examination was made
EP15798640

C17-ARYL SUBSTITUTED BETULINIC ACID ANALOGS

IPC classification:
A61P 31/18, A61K 31/575, A61K 31/58, C07J 63/00
Agent:
Stephanie Anne Learoyd, GlaxoSmithKline
Status:
Request for examination was made
EP15798639

OXOLUPENE DERIVATIVES

IPC classification:
A61P 31/18, A61K 31/575, A61K 31/56, C07J 63/00
Agent:
Stephanie Anne Learoyd, GlaxoSmithKline
Status:
Request for examination was made
EP15801583

EXTENDED BETULINIC ACID ANALOGS

IPC classification:
A61P 31/18, A61K 31/58, A61K 31/56, A61K 31/575, C07J 63/00
Agent:
Stephanie Anne Learoyd, GlaxoSmithKline
Status:
Request for examination was made
EP15801951

CD38 INHIBITORS AND METHODS OF TREATMENT

IPC classification:
C07D 403/04
Applicant:
GlaxoSmithkline Intellectual Property (No. 2) Limited
Agent:
Stephanie Anne Learoyd, GlaxoSmithKline
Status:
Request for examination was made
EP15820976

A PROCESS FOR PREPARING HALOGENATED AZAINDOLE COMPOUNDS USING PYBROP

IPC classification:
A61P 31/18, A61K 31/437, C07F 9/09, C07D 471/04
Agent:
Stephanie Anne Learoyd, GlaxoSmithKline
Status:
Request for examination was made
EP16702069

CYCLIC DINUCLEOTIDES USEFUL FOR THE TREATMENT OF INTER ALIA CANCER

IPC classification:
C07H 19/213, C07F 9/6574, A61P 35/00, A61K 31/52, C07D 473/34, C07D 473/18
Applicant:
GlaxoSmithKline Intellectual Property Development Limited
Agent:
Stephanie Anne Learoyd, GlaxoSmithKline
Status:
Request for examination was made
EP17184312

DERIVATIVES OF BETULIN

IPC classification:
A61P 31/18, A61K 31/56, C07J 63/00
Agent:
Stephanie Anne Learoyd, GlaxoSmithKline
Status:
Request for examination was made
EP16718821

METHODS OF PRODUCING AN HIV MATURATION INHIBITOR

IPC classification:
A61P 31/18, A61K 31/58, C07D 295/155
Agent:
Stephanie Anne Learoyd, GlaxoSmithKline
Status:
Request for examination was made
EP16720285

INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION

IPC classification:
C07D 241/04, C07D 235/08, C07D 333/72, C07D 233/64, C07D 231/56, C07D 231/12, C07D 217/22, C07D 217/08, A61P 31/18, A61K 31/64, A61K 31/428, A61K 31/426, A61K 31/421, A61K 31/42, A61K 31/395, A61K 31/381, C07D 215/38, C07D 215/12, C07C 307/10, C07C 307/06
Agent:
Stephanie Anne Learoyd, GlaxoSmithKline
Status:
Request for examination was made
EP16719712

INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION

IPC classification:
A61P 31/18, A61K 31/4245, A61K 31/18, A61K 31/17, C07D 213/61, C07D 295/192, C07D 285/14, C07D 277/62, C07D 271/12, C07C 237/22, C07D 235/26, C07C 311/03, C07C 275/24, C07D 317/66
Agent:
Stephanie Anne Learoyd, GlaxoSmithKline
Status:
Request for examination was made
EP16717914

IAP E3 LIGASE DIRECTED PROTEOLYSIS TARGETING CHIMERIC MOLECULES

IPC classification:
A61P 35/00, A61K 47/48
Applicant:
GlaxoSmithKline Intellectual Property Development Limited
Agent:
Stephanie Anne Learoyd, GlaxoSmithKline
Status:
Request for examination was made
EP16718817

POLYPEPTIDES TARGETING HIV FUSION

IPC classification:
A61K 38/00, C07K 14/78
Agent:
Stephanie Anne Learoyd, GlaxoSmithKline
Status:
Request for examination was made
EP16810994

NRF2 REGULATORS

IPC classification:
C07C 15/16, C07D 249/18, C07D 249/04, C07D 403/10, C07D 417/10
Applicant:
GlaxoSmithKline Intellectual Property Development Limited
Agent:
Stephanie Anne Learoyd, GlaxoSmithKline
Status:
Request for examination was made
EP16730010

NRF2 REGULATORS

IPC classification:
A61P 25/00, A61P 11/00, A61K 31/4192, C07D 249/18
Applicant:
GlaxoSmithKline Intellectual Property Development Limited
Agent:
Stephanie Anne Learoyd, GlaxoSmithKline
Status:
Request for examination was made
EP16731340

NRF2 REGULATORS

IPC classification:
A61P 13/12, A61P 17/00, A61P 35/00, A61P 25/00, A61P 9/10, A61P 9/12, A61P 37/00, A61P 11/06, A61P 11/00, A61K 31/4192, A61K 31/553, C07D 519/00, C07D 498/04, C07D 267/14, C07D 413/10, C07D 413/06, C07D 403/06
Applicant:
GlaxoSmithKline Intellectual Property Development Limited
Agent:
Stephanie Anne Learoyd, GlaxoSmithKline
Status:
Request for examination was made
EP16735943

INHIBITORS OF INDOLEAMINE 2,3-DIOXYGENASE

IPC classification:
A61P 37/04, A61K 31/69, C07F 5/02
Applicant:
GlaxoSmithKline Intellectual Property Development Limited
Agent:
Stephanie Anne Learoyd, GlaxoSmithKline
Status:
Request for examination was made
EP16736632

PYRIDIN-3-YL ACETIC ACID DERIVATIVES AS INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION

IPC classification:
A61P 31/18, A61K 31/44, C07D 417/14, C07D 401/04, C07D 405/14, C07D 401/14
Agent:
Stephanie Anne Learoyd, GlaxoSmithKline
Status:
Request for examination was made
EP16736633

PYRIDIN-3-YL ACETIC ACID DERIVATIVES AS INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION

IPC classification:
A61P 31/18, A61K 31/44, C07D 409/14, C07D 401/04, C07D 405/14, C07D 401/14
Agent:
Stephanie Anne Learoyd, GlaxoSmithKline
Status:
Request for examination was made
EP16736638

PYRIDIN-3-YL ACETIC ACID DERIVATIVES AS INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION

IPC classification:
C07D 417/04, C07D 413/14, C07D 401/14, A61P 31/00, A61K 31/4545, C07D 401/04
Agent:
Stephanie Anne Learoyd, GlaxoSmithKline
Status:
Request for examination was made
EP16736637

PYRIDIN-3-YL ACETIC ACID DERIVATIVES AS INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION

IPC classification:
C07D 401/14, A61P 31/00, A61K 31/4545, C07D 401/04
Agent:
Stephanie Anne Learoyd, GlaxoSmithKline
Status:
Request for examination was made
EP16806293

CYCLIC PURINE DINUCLEOTIDES AS MODULATORS OF STING

IPC classification:
A61P 35/00, A61P 31/12, A61K 31/7084, C07H 21/00
Applicant:
GlaxoSmithKline Intellectual Property Development Limited
Agent:
Stephanie Anne Learoyd, GlaxoSmithKline
Status:
Request for examination was made
EP17209342

PRODRUGS OF AMINO QUINAZOLINE KINASE INHIBITOR

IPC classification:
A61P 29/00, A61K 31/517, C07D 417/12
Applicant:
GlaxoSmithKline Intellectual Property Development Limited
Agent:
Stephanie Anne Learoyd, GlaxoSmithKline
Status:
Request for examination was made
EP16748147

BETUIN DERIVATIVES FOR PREVENTING OR TREATING HIV INFECTIONS

IPC classification:
A61P 31/18, A61K 31/575, A61K 31/58, C07J 63/00
Applicant:
GlaxoSmithkline Intellectual Property (No. 2) Limited
Agent:
Stephanie Anne Learoyd, GlaxoSmithKline
Status:
Request for examination was made
EP16748353

BETUIN DERIVATIVES FOR PREVENTING OR TREATING HIV INFECTIONS

IPC classification:
A61P 31/18, A61K 31/575, A61K 31/58, C07J 63/00
Applicant:
GlaxoSmithkline Intellectual Property (No. 2) Limited
Agent:
Stephanie Anne Learoyd, GlaxoSmithKline
Status:
Request for examination was made
EP16756807

PYRIDIN-3-YL ACETIC ACID DERIVATIVES AS INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION

IPC classification:
A61P 31/18, A61K 31/444, C07D 401/04
Agent:
Stephanie Anne Learoyd, GlaxoSmithKline
Status:
Request for examination was made
EP16758280

IMIDAZOPYRIDINE MACROCYCLES AS INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION

IPC classification:
A61P 31/18, A61K 31/437, C07D 498/22
Agent:
Stephanie Anne Learoyd, GlaxoSmithKline
Status:
Request for examination was made
EP16758283

5-(N-BENZYL TETRAHYDROISOQUINOLIN-6-YL) PYRIDIN-3-YL ACETIC ACID DERIVATIVES AS INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION

IPC classification:
A61P 31/18, A61K 31/444, C07D 401/04
Agent:
Stephanie Anne Learoyd, GlaxoSmithKline
Status:
Request for examination was made
EP16762868

PYRIDIN-3-YL ACETIC ACID DERIVATIVES AS INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION

IPC classification:
A61P 31/18, A61K 31/444, C07D 487/04, C07D 401/04, C07D 405/14, C07D 401/14
Agent:
Stephanie Anne Learoyd, GlaxoSmithKline
Status:
Request for examination was made
EP16758281

5-(N-FUSED TRICYCLIC ARYL TETRAHYDROISOQUINOLIN-6-YL) PYRIDIN-3- YL ACETIC ACID DERIVATIVES AS INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION

IPC classification:
A61P 31/18, A61K 31/519, A61K 31/4545, C07D 513/14, C07D 495/04, C07D 491/147, C07D 491/048, C07D 487/04, C07D 471/04, C07D 401/14
Agent:
Stephanie Anne Learoyd, GlaxoSmithKline
Status:
Request for examination was made
EP16758282

5-(N-[6,5]-FUSED BICYCLIC ARYL TETRAHYDROISOQUINOLIN-6-YL) PYRIDIN-3-YL ACETIC ACID DERIVATIVES AS INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION

IPC classification:
A61P 31/18, A61K 31/519, A61K 31/52, A61K 31/4545, C07D 513/04, C07D 495/04, C07D 487/04, C07D 473/18, C07D 473/16, C07D 471/04, C07D 417/14, C07D 403/14, C07D 401/14
Agent:
Stephanie Anne Learoyd, GlaxoSmithKline
Status:
Request for examination was made

Please Sign in to use this feature